ArticleMaedica2026
Evaluation of Vitamin B12 Levels in Chronic Spontaneous Urticaria Patients and Correlation with Severity of Disease.
Article in Maedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic spontaneous urticaria (CSU) is a condition with an unclear etiology, which is characterized by recurring hives and/or angioedema. Evidence suggests a potential role of vitamin B12 in modulating immune responses and disease severity. This study explores the relationship between vitamin B12 levels, CSU severity and autoimmunity markers such as autologous serum skin test (ASST) positivity. Methods: A cross-sectional study of 57 CSU patients was conducted. Participants' demographic and clinical characteristics, vitamin B12 levels and ASST positivity were assessed. Symptom severity was measured using urticaria activity scores (UAS), wheal/flare duration and pruritus severity. Associations between vitamin B12 levels, symptom severity and ASST positivity were analysed. Results: Participants had a mean age of 36 years, with a higher share of female subjects. Vitamin B12 deficiency (<200 pg/mL) was observed in 15.7% of patients, while 78.9% had normal levels. A significant negative correlation was found between vitamin B12 levels and wheal/flare duration (p=0.04). Patients with low vitamin B12 levels had longer wheal/flare duration and trends toward higher pruritus severity compared to those with normal levels. Autologous serum skin test positivity was observed in 21% of participants and was associated with more severe symptoms. Conclusion: This study highlights a potential role for vitamin B12 in modulating CSU severity. Assessing vitamin B12 levels in patients with severe or refractory symptoms could aid in personalized management strategies. Further research is needed to validate these findings and explore the role of supplementation in improving CSU outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.